电喷雾质谱法研究聚酰胺、酰亚胺衍生物与HIV-1基因DNA的相互作用

利用电喷雾质谱(ESI-MS)研究了6种识别分子与HIV-1基因调控区DNA的非共价键相互作用. 在研究中比较了不同识别分子与靶序列DNA结合的强弱, 发现双萘酰亚胺衍生物4对此序列DNA具有高亲合性的结合, 并分析了识别分子与DNA复合物的碎裂机理以及结合模式.     

用生物质谱方法研究抗肿瘤双β-咔啉与DNA及核苷酸的非共价结合

利用电喷雾傅里叶变换离子回旋共振质谱研究一系列双β-咔啉化合物与DNA的非共价结合. 发现化合物1—5与5种不同序列的12-mer双链DNA均有明显的非共价结合, 并且有两个β-咔啉环之间连接碳链的长度对此类化合物与双链DNA的非共价结合活性有明显影响. 同时对此类化合物对于DNA非共价结合的序列选择性进行了讨论. 另外还利用电喷雾离子阱质谱研究了双β-咔啉化合物2和4与4种单核苷酸的非共价结合.     

HIV-1病毒DNA与整合酶结合后的构象变化

用分子动力学(MD)模拟方法优化了HIV-1病毒DNA与整合酶(IN)二聚体(IN2)复合物模型结构, 并分析了HIV-1病毒DNA结合IN2后的构象变化. 结果表明, 按照HIV-1病毒DNA与IN2结合能力的强度, 病毒DNA可分为五个区域: 非结合区、强结合区1、弱结合区、强结合区2和反应区, 并用结合自由能计算验证了该分区的合理性. 与未结合IN2的病毒DNA相比, 复合物模型中病毒DNA除了非结合区碱基外, 其它四个区域的碱基构象变化较大. 复合物模型中病毒DNA主链较大程度地偏离标准B型DNA以及结合部位的小沟变宽都是识别IN的结构基础. 模拟结果与实验数据吻合较好, 为基于HIV-1 IN的药物分子设计提供了一定的结构信息.     

基质辅助激光解析电离质谱和电喷雾质谱共同快速确证达托霉素结构

运用基质辅助激光解析电离-飞行时间串联质谱(MALDI-TOF/TOF MS)和电喷雾-四级杆-飞行时间质谱(ESI-Q-TOF MS)快速确证环脂肽达托霉素的结构。首先,ESI检测达托霉素相对分子量为1619.7107,与理论值偏差0.0007。选择其双电荷峰m/z 809.848作为母离子进行ESI串联质谱(MS/MS)测定,成功匹配了达托霉素环外氨基酸序列C9H19CO-Trp-Asn-Asp。其次,优化Li OH裂解达托霉素的实验条件,以MALDITOF/TOF MS监测开环效果,获得95%以上的开环样本后,分别运用MALDI和ESI进行MS/MS测定,达托霉素开环产物的b+和y+全部被匹配,达托霉素全部氨基酸序列得到确证。最后,对开环产物的ESI-MS/MS条件进一步优化,获得了丰富的低端碎片离子,解析了脂肪酸链结构,并绘制了脂肪酸链的裂解图。本方法快速、简便、准确,是确证环脂肽类化合物结构的可靠方法。     

12-钼磷酸中水的存在状态及其热稳定性的质谱法研究

本文运用程序升温脱水-质谱计检测(TPD MS)和红外光谱测定(IR)法研究了12-钼磷酸(PMA)中水的存在状态及其热稳定性. 解迭了PMA的TPD MS谱, 发现PMA中存在有结合能量各异的7种水峰. 讨论了PMA中各种水的结合强度及其对Keggin结构稳定性的影响。     

基于直接注射-多级质谱全扫描技术的人血红蛋白快速肽图分析

利用液相色谱–串联质谱法(LC-MS/MS)进行肽图分析,是目前单克隆抗体等蛋白类药物质量控制的主要方法,然而,LC-MS/MS分析具有费时、费溶剂和成本高等缺点。本研究以人血红蛋白(Human hemoglobin, Hb)为例,考察利用直接注射–多级质谱全扫描技术(DI-MS/MS^ALL)进行肽图分析的可行性。Hb经胰蛋白酶水解后,多肽样品通过流动注射泵直接注入QTOF-MS离子源,采用MS/MS^ALL记录MS¹谱图以及每个单位质荷比窗口(1 Da)的MS²谱图信息,所获得的质谱信息与Skyline软件给出的21个理论肽段质谱信息进行匹配,初步指认了20个肽段。常规的LC-MS/MS肽图分析检测出了所有21个理论肽段。DI-MS/MSALL的MS¹图谱与LC-MS/MS的平均MS¹图谱相近,主要为各肽段带电荷数1～4的准分子离子信号,以双电荷为主,而MS²图谱均以y⁺离子为主。因此,DI-MS/MS^...     

人体结肠癌组织样品中基因组DNA甲基化水平的HPLC—ESI MS／MS检测

利用多重监测反应模式(MRM),通过对液相色谱及质谱条件的优化,建立了人体结肠癌组织样品中基因组DNA甲基化的高效液相色谱-电喷雾质谱(HPLC-ESI MS/MS)检测方法,对结肠癌组织及癌旁组织中基因组DNA甲基化进行了检测.结果表明,5-甲基脱氧胞苷(5mdC)的检出限是1 pg,线性范围为0.037 5～0.5 mg/L,工作曲线相关系数大于0.999 0,该方法的相对标准偏差为2.32%～9.21%.结肠癌病人样品检测结果表明,结肠癌组织基因组DNA甲基化水平低于相应的癌旁组织(P<0.05).     

GC/MS法研究焦炉烟气中多环芳烃类污染物

焦炉烟气中的有机污染物种类繁多 ,但是对人类和生态环境有严重危害的主要是多环芳烃类化合物 [1～ 3] .由于该类化合物结构复杂 ,含量不等 ,因此 ,对其进行分析测试难度很大 .近年来 ,采用色谱 /质谱 (GC/ MS)联机、色谱 /红外 (GC/IR)联机、液相色谱 /质谱联机 (LC/ MS)以及超临界色谱 /质谱联机 (SFC/ MS)等新技术 ,对环境中的多环芳烃类化合物取得了高灵敏度和高选择性的定量分析结果 ,并获得了许多结构信息 .但在我国 ,只对个别地区进行了研究 [4～ 6] ,目前还难以普遍实现 .本文利用气相色谱 /质谱联用法 ,对鞍山钢铁公司炼焦…     

尿苷5′-位磷酰胺的合成及电喷雾电离质谱研究

以三氯氧磷为磷酰化试剂,与尿嘧啶核苷反应,将所得中间产物尿苷磷酰二氯进行胺解,生成具有抗病毒活性的尿苷磷酰胺化合物,目标化合物结构通过核磁确认,并用电喷雾电离串联质谱(ESI MS/MS)仪检测产物,研究了此类化合物的质谱裂解规律,发现了1个类似环磷腺苷的环状裂解碎片,该结果得到密度泛函理论的支持,对尿苷含磷衍生物质谱裂解数据库是一个重要的补充.     

抗抑郁化合物SIPI5358与环糊精形成的非共价复合物

用电喷雾电离质谱(ESI-MS)和串级质谱(MS/MS),并结合紫外光谱、荧光光谱等方法,研究一种芳烷醇哌嗪类抗抑郁化合物SIPI5358与α-、β-、γ-环糊精(CD)制备得到的非共价复合物.质谱分析结果显示,SIPI5358分子可以和α-CD生成配合比为1∶1的非共价复合物,而与β-、γ-CD生成不同配合比的非共价复合物.串级质谱的结果进一步验证β-CD与SIPI5358非共价复合物的组成.用紫外光谱和荧光光谱实验对液相中非共价复合物的形成进行了辅助研究,结果均再次验证了非共价复合物的生成.荧光光谱实验测得SIPI5358与β-CD反应的生成常数Kf=3.45×103 mol.L-1.     

A new high-performance liquid chromatographic/electrospray ionization tandem mass spectrometric method for the simultaneous determination of cyclophosphamide, methotrexate and 5-fluorouracil as markers of surface contamination for occupational exposure monitoring

A new high-performance liquid chromatographic/electrospray ionization tandem mass spectrometric (HPLC/ESI-MS/MS) method was developed for the simultaneous quantification of 5-fluorouracil (5FU), methotrexate (MTX) and cyclophosphamide (CP) in environmental samples. These compounds, commonly used in the treatment of cancer, are recognized as genotoxic. In order to estimate the occupational exposure of hospital personnel handling these drugs, wipe samples were taken from the working surfaces and directly analyzed (with trophosphamide as internal standard) using a reversed-phase capillary column and MS/MS detection. This is the first HPLC/MS/MS method for the simultaneous determination of 5FU, MTX and CP. The present method offers high sensitivity, with detection limits of 1.1 microg l(-1) for MTX and CP and 33.3 microg l(-1) for 5FU, avoiding any sample preconcentration procedure. Rapidity, specificity, high accuracy (mean values between 92.4 and 99.9%) and precision (mean RSD values between 3.4 and 12.1%) make the method suitable for the routine determination of these three antineoplastic drugs.     

Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids

Peptide nucleic acids (PNAs) bind duplex DNA in a sequence-specific manner, creating triplex structures that can provoke DNA repair and produce genome modification. CCR5 encodes a chemokine receptor required for HIV-1 entry into human cells, and individuals carrying mutations in this gene are resistant to HIV-1 infection. Transfection of human cells with PNAs targeted to the CCR5 gene, plus donor DNAs designed to introduce stop codons mimicking the naturally occurring CCR5-delta32 mutation, produced 2.46% targeted gene modification. CCR5 modification was confirmed at the DNA, RNA, and protein levels and was shown to confer resistance to infection with HIV-1. Targeting of CCR5 was achieved in human CD34(+) hematopoietic stem cells (HSCs) with subsequent engraftment into mice and persistence of the gene modification more than four months posttransplantation. This work suggests a therapeutic strategy for CCR5 knockout in HSCs from HIV-1-infected individuals, rendering cells resistant to HIV-1 and preserving immune system function.     

Investigation of the interaction between HⅣ-1 DNA and cyclic peptides by electrospray ionization mass spectrometry

The interaction between HⅣ-1 DNA and five cyclic peptides (CP1-CP5) was investigated using electrospray ionization mass spectrometry (ESI-MS). It revealed that CP1 [c(Ala-Tyr-Leu-Ala-Gly)] and CP4 [c(Pro-D-Tyr-Leu-D-Ala-Gly)] have the higher binding affinity with the duplex DNA among the five cyclic peptides.     

Mass spectrometric detection of CP4 EPSPS in genetically modified soya and maize

The potential of protein fractionation hyphenated to mass spectrometry (MS) to detect and characterize the transgenic protein present in Roundup Ready soya and maize has been investigated. Genetically modified (GM) soya and maize contain the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene from Agrobacterium tumefaciens CP4, which confers resistance to the herbicide glyphosate. The GM soya and maize proteomes were fractionated by gel filtration, anion-exchange chromatography and sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) prior to MS. This facilitated detection of a tryptic peptide map of CP4 EPSPS by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS and nanoelectrospray ionization quadrupole time-of-flight (nanoESI-QTOF) MS. Subsequently, sequence information from the CP4 EPSPS tryptic peptides was obtained by nanoESI-QTOF MS/MS. The identification was accomplished in 0.9% GM soya seeds, which is the current EU threshold for food-labeling requirements.     

Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry

A reliable and easy to use liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the simultaneous quantification of urinary concentrations of cyclophosphamide (CP) and its main metabolites excreted in urine, i.e. N-dechloroethylcyclophosphamide (DCL-CP), 4-ketocyclophosphamide (4KetoCP), and carboxyphosphamide (CarboxyCP). Sample preparation consisted of dilution of urine with an aqueous solution of the internal standard D(4)-CP and methanol, and centrifugation. LC/MS/MS detection was performed using a triple-quadrupole mass spectrometer working in selected reaction monitoring mode. All analytes were quantified in a single run within 11.5 min. The limits of detection were 5 ng/mL for CP and 4KetoCP, 1 ng/mL for DCL-CP, and 30 ng/mL for CarboxyCP. Quantification ranges were adjusted to the expected concentrations in 24-h urine collections of patients treated with a polychemotherapy regimen (3-175 microg/mL for CP, 0.5-27 microg/mL for 4KetoCP and 0.17-9 microg/mL for CarboxyCP and DCL-CP, respectively). The method was validated according to international guidelines of the ICH and the FDA.     

Investigation of non-covalent complexes of HIV-1 promoter DNA and polyamides containing N-methylpyrrole by electrospray ionization mass spectrometry

Eight novel polyamides containing N-methylpyrrole were designed to target the sequence (5'-CTGCATATAAGCAG-3'/5'-CTGCTTATATGCAG-3') of the TATA box element of the HIV-1 promoter DNA. The non-covalent complexes of the promoter DNA and the polyamides were investigated by electrospray ionization (ESI) mass spectrometry, which provided strong evidence for the binding of the novel polyamides to the sequence of the TATA box element. It also revealed that polyamide 2 (PyPyPyPybetaDp), a potent binder of HIV-1 promoter DNA and a lead molecule for the design of new anti-HIV-1 drugs, had the highest binding affinity with the TATA box element DNA among these polyamides by examining the stoichiometry and the selectivity.     

Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

The alkylating agents cyclophosphamide (CP) and N, N', N"-triethylenethiophosphoramide (thiotepa) are often co-administered in high-dose chemotherapy regimens. Since these regimens can be complicated by the occurrence of severe and sometimes life-threatening toxicities, pharmacokinetically guided administration of these compounds, to reduce variability in exposure, may lead to improved tolerability. For rapid dose adaptations during a chemotherapy course, we have developed and validated an assay, using liquid chromatography coupled with electrospray tandem mass spectrometry (LC/MS/MS), for the routine quantification of CP, thiotepa and their respective active metabolites 4-hydroxycyclophosphamide (4OHCP) and N, N', N"-triethylenephosphoramide (tepa) in plasma. Because of the instability of 4OHCP in plasma, the compound is derivatized with semicarbazide (SCZ) immediately after sample collection and quantified as 4OHCP-SCZ. Sample pretreatment consisted of protein precipitation with a mixture of methanol and acetronitrile using 100 microl of plasma. Chromatographic separation was performed on an Zorbax Extend C18 column (150 x 2.1 mm i.d., particle size 5 microm), with a quick gradient using 1 mM ammonia solution and acetonitrile, at a flow-rate of 0.4 ml min(-1). The analytical run time was 10 min. The triple quadrupole mass spectrometer was operating in the positive ion mode and multiple reaction monitoring was used for drug quantification. The method was validated over the concentration ranges 200-40,000 ng ml(-1) for CP, 50-5000 ng ml(-1) for 4OHCP-SCZ and 5-2500 ng ml(-1) for thiotepa and tepa, using 100 microl of human plasma. These dynamic concentration ranges proved to be relevant in daily practice. Hexamethylphosphoramide was used as an internal standard. The coefficients of variation were <12% for both intra-day and inter-day precisions for each compound. Mean accuracies were also between the designated limits (+/- 15%). This robust and rapid LC/MS/MS assay is now successfully applied for routine therapeutic drug monitoring of CP, thiotepa and their metabolites in our hospital.     

Interactions of phosphorylated cyclohexapeptides with uranyl: insights from experiments and theoretical calculations

Two phosphorylated cyclohexapeptides (CPs) bearing one (CP1) or two phosphates (CP2) were synthesized to explore the interactions between uranyl ions and very small cyclic peptides. According to the results of the ESI–MS and fluorescence titrations, the 1:1 uranyl-CPs complexes are the main products with the affinity constants of 7.3?×?10⁴ and 2.0?×?10⁵ for CP1 and CP2, respectively. Density functional theory calculations indicate phosphoryl and carboxyl groups coordinate uranyl in mono-dentate and bi-dentate fashions due to steric effects, which is consistent with the results of extended X-ray absorption fine structure spectroscopy.

     

Difference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluid

Alterations in the pancreatic fluid proteome of individuals with chronic pancreatitis (CP) may offer insights into the development and progression of the disease. The endoscopic pancreatic function test (ePFT) can safely collect large volumes of pancreatic fluid that are potentially amenable to proteomic analyses using difference gel electrophoresis (DIGE) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pancreatic fluid was collected endoscopically using the ePFT method following secretin stimulation from three individuals with severe CP and three chronic abdominal pain (CAP) controls. The fluid was processed to minimize protein degradation and the protein profiles of each cohort, as determined by DIGE and LC-MS/MS, were compared. This DIGE-LC-MS/MS analysis reveals proteins that are differentially expressed in CP compared with CAP controls. Proteins with higher abundance in pancreatic fluid from CP individuals include: actin, desmoplankin, α-1-antitrypsin, SNC73, and serotransferrin. Those of relatively lower abundance include carboxypeptidase B, lipase, α-1-antichymotrypsin, α-2-macroglobulin, actin-related protein (Arp2/3) subunit 4, glyceraldehyde-3-phosphate dehydrogenase, and protein disulfide isomerase. Endoscopic collection (ePFT) in tandem with DIGE-LC-MS/MS is a suitable approach for pancreatic fluid proteome analysis; however, further optimization of our protocol, as outlined herein, may improve proteome coverage in future analyses.